T cell engagers for solid tumors is a subset of T cell engagers that are explicitly designed to target solid tumor indications.

Targeted alpha therapy is a cutting-edge form of radiopharmaceuticals that use alpha-emitting isotopes to deliver highly potent, localized radiation directly to cancer cells, sparing healthy tissues.

Tumor-activated therapeutics are, as the name implies, therapeutics that are designed to become active in the tumor. How is this done, what are the advantages, and who is doing it?

Gene delivery that acts as a form of immunotherapy. That is, the gene therapy is meant to act on an immune cell population and induce anti-cancer effects.